Arnica Montana and Bellis Perennis for Prevention of Seroma After Mastectomy (NCT03512639) | Clinical Trial Compass
CompletedNot Applicable
Arnica Montana and Bellis Perennis for Prevention of Seroma After Mastectomy
55 participantsStarted 2016-01-01
Plain-language summary
Arnica montana and Bellis perennis for Prevention of Seroma Following Mastectomy.
Who can participate
Age range18 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Female patients, aged over 18 years.
* Patients underwent mastectomy, either for breast cancer or for risk reduction, followed by immediate breast reconstruction.
* All subjects signed informed consent forms. -
Exclusion Criteria:
* Conditions which could affect wound-healing
* Coagulation problems (autoimmune and hematological diseases, etc.)
* Medication which affects the immunological or hematological system (steroids, anticoagulants, chemotherapeutic agents, etc.)
* Unbalanced background diseases.
* Active smokers were instructed to stop smoking at least three weeks prior to surgery and a month postoperatively.
What they're measuring
1
Reduction of post operative seroma following mastectomy and reconstruction.